{"id":886,"date":"2021-10-30T12:33:02","date_gmt":"2021-10-30T15:33:02","guid":{"rendered":"https:\/\/ondawebhost4.com.br\/vita\/en\/?post_type=noticias&p=886"},"modified":"2022-04-18T14:21:54","modified_gmt":"2022-04-18T17:21:54","slug":"anvisa-the-addition-to-the-application-of-origin-should-be-submitted-by-electronic-system-sistema-solicita","status":"publish","type":"noticias","link":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/10\/30\/anvisa-the-addition-to-the-application-of-origin-should-be-submitted-by-electronic-system-sistema-solicita\/","title":{"rendered":"ANVISA \u2013 The addition to the application of origin should be submitted by electronic system – Sistema Solicita"},"content":{"rendered":"

In order to improve the link between applications for addition to their respective applications of origin, as well as to reduce the timeline and standardize these procedures, ANVISA have informed that, from November, applications for additional data of Drug Products (DP) and Active Pharmaceutical Ingredients (API) Marketing Authorization and\/or Variation, as well as application related to Clinical Trials must be submitted by the electronic system, called \u201cSistema Solicita\u201d.<\/p>\n

It is important to mention that, according to Brazilian Legislation RDC 204\/2005, additions are tools to be used as a complement to the process related to a specific subject, which is limited to improving knowledge of the object of the process, not resulting in different information than the one requested.<\/p>\n

Access the complete new on ANVISA\u2019s website: https:\/\/bit.ly\/3G6dPpR.<\/p>\n

Count on Vita to assist your company in developing drug products registration and post-registration projects in Latin America.<\/p>\n","protected":false},"author":1,"featured_media":887,"template":"","meta":{"inline_featured_image":false,"_links_to":"","_links_to_target":""},"categorias":[22],"yoast_head":"\nANVISA \u2013 The addition to the application of origin should be submitted by electronic system - Sistema Solicita - Vita<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/10\/30\/anvisa-the-addition-to-the-application-of-origin-should-be-submitted-by-electronic-system-sistema-solicita\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ANVISA \u2013 The addition to the application of origin should be submitted by electronic system - Sistema Solicita - Vita\" \/>\n<meta property=\"og:description\" content=\"In order to improve the link between applications for addition to their respective applications of origin, as well as to reduce the timeline and standardize these procedures, ANVISA have informed that, from November, applications for additional data of Drug Products (DP) and Active Pharmaceutical Ingredients (API) Marketing Authorization and\/or Variation, as well as application related... Leia mais »\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/10\/30\/anvisa-the-addition-to-the-application-of-origin-should-be-submitted-by-electronic-system-sistema-solicita\/\" \/>\n<meta property=\"og:site_name\" content=\"Vita\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-18T17:21:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2022\/03\/Imagem-77.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/10\/30\/anvisa-the-addition-to-the-application-of-origin-should-be-submitted-by-electronic-system-sistema-solicita\/\",\"url\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/10\/30\/anvisa-the-addition-to-the-application-of-origin-should-be-submitted-by-electronic-system-sistema-solicita\/\",\"name\":\"ANVISA \u2013 The addition to the application of origin should be submitted by electronic system - Sistema Solicita - Vita\",\"isPartOf\":{\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/#website\"},\"datePublished\":\"2021-10-30T15:33:02+00:00\",\"dateModified\":\"2022-04-18T17:21:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/10\/30\/anvisa-the-addition-to-the-application-of-origin-should-be-submitted-by-electronic-system-sistema-solicita\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/10\/30\/anvisa-the-addition-to-the-application-of-origin-should-be-submitted-by-electronic-system-sistema-solicita\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/10\/30\/anvisa-the-addition-to-the-application-of-origin-should-be-submitted-by-electronic-system-sistema-solicita\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Not\u00edcias\",\"item\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ANVISA \u2013 The addition to the application of origin should be submitted by electronic system – Sistema Solicita\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/#website\",\"url\":\"https:\/\/www.vitapharmaconsulting.com\/en\/\",\"name\":\"Vita\",\"description\":\"Regulatory affairs & consulting\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.vitapharmaconsulting.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"pt-BR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ANVISA \u2013 The addition to the application of origin should be submitted by electronic system - Sistema Solicita - Vita","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/10\/30\/anvisa-the-addition-to-the-application-of-origin-should-be-submitted-by-electronic-system-sistema-solicita\/","og_locale":"pt_BR","og_type":"article","og_title":"ANVISA \u2013 The addition to the application of origin should be submitted by electronic system - Sistema Solicita - Vita","og_description":"In order to improve the link between applications for addition to their respective applications of origin, as well as to reduce the timeline and standardize these procedures, ANVISA have informed that, from November, applications for additional data of Drug Products (DP) and Active Pharmaceutical Ingredients (API) Marketing Authorization and\/or Variation, as well as application related... Leia mais »","og_url":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/10\/30\/anvisa-the-addition-to-the-application-of-origin-should-be-submitted-by-electronic-system-sistema-solicita\/","og_site_name":"Vita","article_modified_time":"2022-04-18T17:21:54+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2022\/03\/Imagem-77.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/10\/30\/anvisa-the-addition-to-the-application-of-origin-should-be-submitted-by-electronic-system-sistema-solicita\/","url":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/10\/30\/anvisa-the-addition-to-the-application-of-origin-should-be-submitted-by-electronic-system-sistema-solicita\/","name":"ANVISA \u2013 The addition to the application of origin should be submitted by electronic system - Sistema Solicita - Vita","isPartOf":{"@id":"https:\/\/www.vitapharmaconsulting.com\/en\/#website"},"datePublished":"2021-10-30T15:33:02+00:00","dateModified":"2022-04-18T17:21:54+00:00","breadcrumb":{"@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/10\/30\/anvisa-the-addition-to-the-application-of-origin-should-be-submitted-by-electronic-system-sistema-solicita\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/10\/30\/anvisa-the-addition-to-the-application-of-origin-should-be-submitted-by-electronic-system-sistema-solicita\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/10\/30\/anvisa-the-addition-to-the-application-of-origin-should-be-submitted-by-electronic-system-sistema-solicita\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Not\u00edcias","item":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/"},{"@type":"ListItem","position":2,"name":"ANVISA \u2013 The addition to the application of origin should be submitted by electronic system – Sistema Solicita"}]},{"@type":"WebSite","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/#website","url":"https:\/\/www.vitapharmaconsulting.com\/en\/","name":"Vita","description":"Regulatory affairs & consulting","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vitapharmaconsulting.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"pt-BR"}]}},"_links":{"self":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/noticias\/886"}],"collection":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/noticias"}],"about":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/types\/noticias"}],"author":[{"embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/users\/1"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/media\/887"}],"wp:attachment":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/media?parent=886"}],"wp:term":[{"taxonomy":"categorias","embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/categorias?post=886"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}